Loading company…
Paris biopharma firm founded in 2010 developing therapies for chronic diseases, with Bone Therapeutics agreeing to buy 51% in 2022.
Medsenic SAS, established in 2010 in Paris, France, develops therapeutic solutions for chronic diseases using biomedical technology. In August 2022 Bone Therapeutics SA agreed to acquire a 51% stake for an undisclosed amount. The company's August 2022 funding round raised EUR 1.941 million, led by Capital Grand Est, and its current valuation is EUR 16.948 million. It reported revenue of EUR 0.00 and EBITDA of EUR -619,456.90 in the most recent year, and plans to expand into Europe and North America by 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in